You can learn more about this trial by viewing a short informational video featuring Dr. Christopher Sweeney, the study chair for this trial:
Click here for a list of institutions participating in this trial
This study is for prostate cancer patients whose disease has spread to four or more sites in the bones or to the liver. The standard of care for these patients is to give hormonal therapy and then observe, giving chemotherapy if the disease progresses or recurs. The trial is looking at the potential benefit of giving chemotherapy immediately after hormonal therapy.
Patients participating in the study will be randomized to one of two treatment groups:
Patients will be followed for up to ten years to assess the effects of the study treatments.
You can learn more about prostate cancer by visiting these web sites:
National Cancer Institute Information On Prostate Cancer
USTOO - Prostate Cancer Information And Support
Information about cancer clinical trials can be found at: